CHANGE IN RATINGS
Burlington Northern Santa Fe
( BNI) upgraded at Goldman to its Conviction Buy List based on valuation. Also cites best in class intermodal franchise and company is taking share from Union Pacific. Raised target price to $72 from $66.
downgraded at UBS from Neutral to Sell. $3.80 price target. Expect lower advertising estimates through 2010. Credit rating could also be cut.
Church & Dwight
upgraded at Oppenheimer to Outperform, Oppenheimer said. $62 price target. Company should benefit as consumers trade down toward its value-oriented portfolio.
downgraded at Credit Suisse to Neutral from Outperform based on weak freight outlook in 2009 and expectations for lower utilization for two older vessels. Lowered target price to $2 from $5.
added to Goldman Conviction Buy List based on improving sales trends in coming months and valuation. Raised target price to $15 from $14.
downgraded at Credit Suisse to Neutral from Outperform. Cites liquidity tensions over next few months and further pressure on subsidiary capital levels. Lowered target price to $14 from $23.
( NLC) upgraded at Goldman to Buy based on better refinancing outlook and valuation -- since company trades at a 25% discount to peers. Sets 6-month target price at $16.
downgraded at Soleil to Hold from Buy based on short-term fertilizer demand destruction and longer-term lower potash prices. Lowered target price to $100.
downgraded at UBS from Neutral to Sell. $44 price target. Valuation call, as the company is likely facing a volatile year. Insider selling has also remained steady.
STOCK COMMENTS / EPS CHANGES
target raised at UBS to $54. Stock has moved higher on GSK takeover rumors. Maintain Buy rating, as earnings look too conservative. The pipeline also has good potential.
Credit Suisse is
2009 and 2010 EPS estimates on DE based on weaker farm equipment demand and more cautious outlook from farmers. Lowered target price to $40 from $41.
added to Top Picks Live list at Citigroup. Valuation call, even though estimates were cut because of lower investment income. Buy rating and new $35 price target.
estimates, target reduced at Barclays. Shares now seen reaching $14, Barclays Capital said. Estimates also cut, to reflect the new margin guidance given at the company's analyst meeting. Equal-weight rating.
This article was written by a staff member of TheStreet.com.